This content is from: Home
Merck wins interim relief against Teva
The High Court in London has granted an interim injunction against Teva to stop it launching a generic version of efavirenz, even though Teva had done nothing more than get market authorisation
To access our in-house intelligence please request a trial here.
Read this article – and more – for a 30 day period.
REQUEST ACCESSAre you already an Managing IP subscriber? Login here